Nikko Asset Management Americas, Inc. 13D and 13G filings for Seres Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 06:05 am Sale |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
Nikko Asset Management Americas, Inc. | 785,519 0.860% |
-5,038,084 (-86.51%) |
Filing |
| 2021-02-11 5:26 pm Purchase |
2020-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
Nikko Asset Management Americas, Inc. | 5,823,603 6.380% |
198,613 (+3.53%) |
Filing |
| 2020-09-08 1:28 pm Sale |
2020-08-31 | 13G | Seres Therapeutics, Inc. MCRB |
Nikko Asset Management Americas, Inc. | 5,624,990 6.300% |
-2,648,233 (-32.01%) |
Filing |